People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...

After living with cystic fibrosis for over 20 years, Nicole Heller, of Norwalk, received a second chance at life through a ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Researchers at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation ...

GOTHENBURG, SE / ACCESS Newswire / April 29, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The 12-month ...

The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

Molecular testing is transforming post-transplant care, reducing the need for invasive biopsies and personalizing medication ...

Advancements in heart transplant technology, focusing on machine perfusion's role in extending the time window for organ ...

Findings on tacrolimus use in lung transplant patients, showing its effectiveness over cyclosporine in preventing chronic ...

One heart retrieval method exhibited lower risk during donation after circulatory death, according to results from an international, multicenter study shared at the International Society for Heart and ...

27 April 2025, Boston—Researchers at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT) marked the 10-year anniversary of modern ...